一种依赖的抗生素,源自一种依赖的抗生素
Shao-Lun Chiou1, Yi-Ju Chen1, Chu-Ting Lee1
1Department of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei City, 10617, Taiwan.
Angewandte Chemie (International ed. in English)
|December 12, 2023
概括
研究人员开发了一种不需要的新型抗生素,克服了对依赖的抗生素 (CDA) 的关键挑战. 这种新的依赖药物有效地对抗MRSA和VRE等耐药细菌.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 耐药性细菌病原体构成了严重的全球健康威胁.
- 取决于的抗生素 (CDA) 提供了针对耐药细菌的新型作用机制 (MOA).
- 依赖性限制了许多CDA的治疗潜力.
研究的目的:
- 为了设计一种具有减少或消除依赖的拉斯巴托米辛C (LspC) 的合成模拟物.
- 调查CDA活动的替代诱导机制.
- 开发一种新的依赖抗生素.
主要方法:
- 合成修改拉斯巴托米辛C (LspC) 来制造B1模拟物,用血清替代协调残留物.
- 使用酸 (PBA) 诱导B1活性,以形成酸.
- 使用薄层染色学,质谱学 (MS) 和核磁共振 (NMR) 进行表征.
- 通过补充试验评估抗菌活性和MOA.
主要成果:
- 创造了一种合成的LspC模拟物 (B1),它可以独立于发挥作用,其活性由酸 (PBA) 诱导.
- B1通过隔离无二烯酸来抑制细菌生长,这是与LspC相同的MOA.
- B1的效力和疗效与LspC对抗格兰阳性细菌的效力和疗效相似,包括耐甲基黄金葡萄球菌 (MRSA) 和耐万科胺菌 (VRE).
结论:
- 将CDA转化为依赖的抗生素是可行的.
- 这一战略为设计和控制抗生素功能提供了一种新的方法.
- 开发B1为对抗耐药性细菌感染提供了一个有希望的替代方案.
相关概念视频
Antibiotic Selection
54.1K
Overview
54.1K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antimicrobial Proteins
1000
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1000
Receptor-mediated Endocytosis
6.1K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.1K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


